Skip to main content
. Author manuscript; available in PMC: 2022 Apr 24.
Published in final edited form as: Neurotox Res. 2022 Jan 19;40(2):373–383. doi: 10.1007/s12640-021-00469-0

Fig. 3.

Fig. 3.

Suppressed neuroinflammation in Gpx4NIKO mice treated with Lip-1. Images of lumbar spinal cord sections from Control mice, Vehicle mice and Lip-1 mice at day 10 of treatment stained with an anti-Iba-1 antibody (a) or an anti-GFAP antibody (b). c. Western blots showing levels of GFAP and Iba-1 in spinal cord tissues from Control mice, Vehicle mice and Lip-1 mice. d. Quantified results of GFAP and Iba-1 protein levels. e. Results of GFAP and Iba-1 mRNA levels. n=3, *: p<0.05.